INR 89.39
(0.6%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Operating Cash Flow | 1.5 Billion | 1.54 Billion | 1.05 Billion | 1.63 Billion | 1.54 Billion | 1.27 Billion |
Net Income | 322.12 Million | 584.94 Million | 430.41 Million | 418.09 Million | 424.01 Million | 815.62 Million |
Depreciation & Amortization | 843.3 Million | 800.66 Million | 754.85 Million | 659.43 Million | 625.2 Million | 614.86 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | 572 Thousand | -40.39 Million | -137.93 Million | 328.85 Million | 299.16 Million | -190.85 Million |
Other non-cash items | 2.02 Billion | 198.33 Million | 8.07 Million | 227.61 Million | 192.07 Million | 36.52 Million |
Investing Cash Flow | -1.43 Billion | -649.83 Million | -758.4 Million | -498.96 Million | -1.43 Billion | -1.95 Billion |
Investments in PPE | -1.44 Billion | -672.16 Million | -777.43 Million | -516.7 Million | -1.38 Billion | -1.91 Billion |
Acquisitions | 13.26 Million | 7.66 Million | 15.89 Million | 6.81 Million | 10.31 Million | 3.04 Million |
Investment purchases | - | -7.66 Million | - | - | -66.68 Million | -40.59 Million |
Sales/Maturities of investments | - | 11.2 Million | - | - | -10.31 Million | -3.04 Million |
Other Investing Activities | 41.95 Million | 11.12 Million | 3.14 Million | 10.92 Million | 17.65 Million | 8.92 Million |
Financing Cash Flow | -114.84 Million | -867.46 Million | -286.09 Million | -1.12 Billion | -96.07 Million | 659.88 Million |
Debt repayment | -26.29 Million | -916.82 Million | -1.26 Billion | -637.22 Million | -964.18 Million | -348.47 Million |
Dividends payments | -75.77 Million | -54.12 Million | -54.12 Million | -27.06 Million | -65.25 Million | -54.12 Million |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | -148.4 Million | 103.48 Million | 1.03 Billion | -463.89 Million | 922.24 Million | 1.06 Billion |
Accounts receivables | -419.68 Million | 114.11 Million | -342.42 Million | -62.83 Million | 327.45 Million | -296.71 Million |
Accounts payables | 1.05 Billion | -230.99 Million | 784.96 Million | 694.6 Million | -494.66 Million | -226.84 Million |
Inventory | -634.59 Million | 76.48 Million | -580.47 Million | -302.91 Million | 466.37 Million | 332.69 Million |
Other working capital | 1.05 Billion | - | - | - | - | - |
Cash at beginning of period | 63.51 Million | 32.91 Million | 21.99 Million | 15.15 Million | 9.14 Million | 23.4 Million |
Cash at end of period | 24.48 Million | 59.17 Million | 32.91 Million | 21.99 Million | 15.15 Million | 9.14 Million |
Capital Expenditure | -1.44 Billion | -672.16 Million | -777.43 Million | -516.7 Million | -1.38 Billion | -1.91 Billion |
Effect of forex changes on cash | - | 1.00 | -1.00 | - | - | - |
Net cash flow / Change in cash | -39.03 Million | 26.25 Million | 10.92 Million | 6.84 Million | 6 Million | -14.25 Million |
Free Cash Flow | 62.39 Million | 871.38 Million | 277.97 Million | 1.11 Billion | 151.11 Million | -642.47 Million |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Operating Cash Flow | - | - | - | - | - | - |
Net Income | 53.84 Million | 112.28 Million | 322.12 Million | 67.15 Million | 91.04 Million | 51.65 Million |
Depreciation & Amortization | - | - | 843.3 Million | 209.21 Million | 214.55 Million | 210.8 Million |
Deferred income taxes | - | - | - | - | - | - |
Stock-based compensation | - | - | - | - | - | - |
Change in working capital | - | - | 572 Thousand | - | - | - |
Other non-cash items | -53.84 Million | -112.28 Million | 2.02 Billion | -67.15 Million | -91.04 Million | -51.65 Million |
Investing Cash Flow | - | - | -1.43 Billion | - | - | - |
Investments in PPE | - | - | -1.44 Billion | - | - | - |
Acquisitions | - | - | 13.26 Million | - | - | - |
Investment purchases | - | - | - | - | - | - |
Sales/Maturities of investments | - | - | - | - | - | - |
Other Investing Activities | - | - | 41.95 Million | - | - | - |
Financing Cash Flow | - | - | -114.84 Million | - | - | - |
Debt repayment | - | - | -26.29 Million | - | - | - |
Dividends payments | - | - | -75.77 Million | - | - | - |
Common Stock Repurchased | - | - | - | - | - | - |
Common Stock Issuance | - | - | - | - | - | - |
Other Financing Activities | - | - | -148.4 Million | - | - | - |
Accounts receivables | - | - | -419.68 Million | - | - | - |
Accounts payables | - | - | 1.05 Billion | - | - | - |
Inventory | - | - | -634.59 Million | - | - | - |
Other working capital | - | - | - | - | - | - |
Cash at beginning of period | - | - | 63.51 Million | 36.47 Million | -392.63 Million | 63.51 Million |
Cash at end of period | - | - | 24.48 Million | 454.89 Million | 36.47 Million | 485.12 Million |
Capital Expenditure | - | - | -1.44 Billion | - | - | - |
Effect of forex changes on cash | - | - | - | - | - | - |
Net cash flow / Change in cash | - | - | -39.03 Million | 418.42 Million | 429.1 Million | 421.6 Million |
Free Cash Flow | - | - | 62.39 Million | 418.42 Million | 429.1 Million | 421.6 Million |
MKTX
CBOE
3883
LALIN
3741
MEDPLUS